Skip to main content
EPRX logo

Eupraxia Pharmaceuticals Inc.

EPRXNASDAQHealthcareBiotechnology

$6.85Today:- (-)1Y +33.63%

As of Oct 26, 2026 close

Market cap
$453.62M
P/E (TTM)
-
Forward P/E
-
Dividend yield
-
52-week range
$5.25$9.32
Volume (live)
-
Avg. volume (3M)
817.44K

Eupraxia Pharmaceuticals Inc. (EPRX) Analyst Forecast

Analyst consensus ratings, 12-month price targets, and expert recommendations for Eupraxia Pharmaceuticals Inc. stock.

Analyst Consensus Rating

Investment consensus from 8 professional research analysts

Consensus Rating

Buy
Based on 8 unique analysts
(16 total ratings in last 90 days)
Medium Confidence∞:1 Buy/Sell

Average Price Target

$17.00
+148.18% upside

Loading chart...

Strong Sell
Sell
Hold
Buy
Strong Buy

Latest EPRX Analyst Ratings & Recommendations

Recent analyst recommendations with rating changes and price target updates (last 90 days)

Brandon Folkes
HC Wainwright
BuyReiterates
$11.00
Kristen Kluska
Cantor Fitzgerald
BuyMaintains
$19.00
David Martin PhD
Bloom Burton
BuyMaintains
$14.00
Martin Fan
Wedbush
BuyMaintains
$17.00
Brandon Folkes
HC Wainwright
BuyReiterates
$11.00
Sam Slutsky
LifeSci Capital
BuyMaintains
$16.00
Lachlan Hanbury Brown
William Blair
BuyMaintains
-
Annabel Samimy
Stifel Nicolaus
BuyReiterates
$25.00
Martin Fan
Wedbush
BuyInitiates
$17.00
Brandon Folkes
HC Wainwright
BuyMaintains
$11.00
Sam Slutsky
LifeSci Capital
BuyMaintains
$16.00
Lachlan Hanbury Brown
William Blair
BuyMaintains
-
Kristen Kluska
Cantor Fitzgerald
BuyReiterates
$19.00
Jay Olson
Oppenheimer
BuyMaintains
$17.00
Kristen Kluska
Cantor Fitzgerald
BuyReiterates
$19.00
David Martin PhD
Bloom Burton
BuyMaintains
$14.00

Source: Professional analyst ratings and price targets from the last 90 days. Data as of Oct 20, 2026. Data sources and methodology

Frequently Asked Questions

What is the analyst consensus rating for EPRX?

The analyst consensus rating for EPRX is Buy, based on the latest ratings from 8 analysts over the last 90 days.

What is the average price target for EPRX?

The average 12-month price target for EPRX is $17.00, representing an upside of 148.2% from the Oct 26, 2026 close of $6.85.

What do analyst ratings mean?

Analyst ratings indicate investment recommendations: Strong Buy and Buy are bullish signals suggesting the stock may outperform. Hold means the stock is fairly valued. Sell and Strong Sell are bearish signals suggesting potential underperformance. These ratings are based on fundamental analysis and valuation models.

What is a price target?

A price target is an analyst's projection of a stock's fair value over a specific timeframe, typically 12 months. Analysts use fundamental analysis, financial modeling, and industry comparisons to estimate where the stock should trade. Price targets can range from low (conservative) to high (optimistic) estimates.